AVXL Highlights Regulatory Momentum and Achieves Rare Net Income with Cost Reversals—Key Alzheimer's and Rett Milestones Ahead
Market Chameleon (Tue, 25-Aug 11:44 AM)
Anavex Life Sciences GAAP EPS of $0.08
at seekingalpha.com (Tue, 25-Aug 8:04 AM)
Anavex Life Sciences GAAP EPS of -$0.08
